YESHWANT KRISHNA reported 3 transactions at VERVE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/22/2021ACC: 0000899243-21-025307
Director10% Owner
Since Jun 2021
-89.15M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
6
Total transactions
10.79M acquired · 99.94M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+6.32M
Price / share
—
Trade value
—
% of position
New position
6/21/2021
0.00→6.32M
Common Stock
Indirect
Shares
+4.03M
Price / share
—
Trade value
—
% of position
New position
6/21/2021
0.00→4.03M
Common Stock
Indirect
Shares
+443.26K
Price / share
—
Trade value
—
% of position
11.0%
6/21/2021
4.03M→4.47M
Total
Net shares
+10.79M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/21/2021 | C · Conversion | +6.32M | — | — | New position | 0.00 | 6.32M |
| Common Stock Indirect | 6/21/2021 | C · Conversion | +4.03M | — | — | New position | 0.00 | 4.03M |
| Common Stock Indirect | 6/21/2021 | C · Conversion | +443.26K | — | — | 11.0% | 4.03M | 4.47M |
| Total | +10.79M | $0.00 | ||||||
Derivative Transactions3
Series A Preferred Stock
Indirect
Converts to
Common Stock
6.32M shares
Shares
−58.53M
Strike price
Held after
0.00
Exercisable
—
6/21/2021
Series A-2 Preferred Stock
Indirect
Converts to
Common Stock
4.03M shares
Shares
−37.31M
Strike price
Held after
0.00
Exercisable
—
6/21/2021
Series B Preferred Stock
Indirect
Converts to
Common Stock
443.26K shares
Shares
−4.10M
Strike price
Held after
0.00
Exercisable
—
6/21/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock6.32M shares | 6/21/2021 | C · Conversion | −58.53M | — | 0.00 | |
| Series A-2 Preferred Stock Indirect | Common Stock4.03M shares | 6/21/2021 | C · Conversion | −37.31M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock443.26K shares | 6/21/2021 | C · Conversion | −4.10M | — | 0.00 |